参考文献/References:
[1] PASINA L,RIZZI B,NOBILI A,et al.Anticholinergic load and delirium in end-of-life patients[J].Eur J Clin Pharmacol,2021,77(9):1419-1424.
[2] SEILER A,SCHUBERT M,HERTLER C,et al.Predisposing and precipitating risk factors for delirium in palliative care patients[J].Palliat Support Care,2020,18(4):437-446.
[3] NEEFJES E C W,VAN DER VORST M J D L,VERDEGAAL B A T T,et al.Identification of patients with cancer with a high risk to develop delirium[J].Cancer Med,2017,6(8):1861-1870.
[4] KLANKLUANG W,TONGSAI S,SRIPHIROM C,et al.The prevalence,associated factors,clinical impact,and state of diagnosis of delirium in palliative care patients[J].Support Care Cancer,2021,29(12):7949-7956.
[5] 冯勤,李玲,马望,等.癌症终末期患者谵妄的发生情况及影响因素分析[J].中华护理杂志,2019,54(2):238-243.
[6] MORITA T,TEI Y,INOUE S.Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients:prevalence and identification of research focus[J].J Pain Symptom Manage,2003,26(3):827-834.
[7] HARTLING L,FEATHERSTONE R,NUSPL M,et al.Grey literature in systematic reviews:a cross-sectional study of the contribution of non-English reports,unpublished studies and dissertations to the results of Meta-analyses in child-relevant reviews[J/OL].[2022-07-10].https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-017-0347-z.DOI:10.1186/s12874-017-0347-z.
[8] UCHIDA M,OKUYAMA T,ITO Y,et al.Prevalence,course and factors associated with delirium in elderly patients with advanced cancer:a longitudinal observational study[J].Jpn J Clin Oncol,2015,45(10):934-940.
[9] PLASCHKE K,PETERSON K A,FRANKENHAUSER S,et al.The impact of plasma cholinergic enzyme activity and other risk factors for the development of delirium in patients receiving palliative care[J].J Pain Symptom Manage,2016,52(4):525-532.
[10]KANBAYASHI Y,HATANO Y,HATA Y,et al.Predictive factors for agitation severity of hyperactive delirium in terminally ill cancer patients in a general hospital using ordered logistic regression analysis[J].J Palliat Med,2013,16(9):1020-1025.
[11]杨婉,涂佳,郑凯曦.晚期癌症患者谵妄发生的影响因素分析[J].健康研究,2021,41(2):205-208,217.
[12]KELAVA I,CHIARADIA I,PELLEGRINI L,et al.Androgens increase excitatory neurogenic potential in human brain organoids[J].Nature,2022,602(7895):112-116.
[13]MATSUO N,MORITA T,MATSUDA Y,et al.Predictors of delirium in corticosteroid-treated patients with advanced cancer:an exploratory,multicenter,prospective,observational study[J].J Palliat Med,2017,20(4):352-359.
[14]DAVILA M L,SAUTER C,BRENTJENS R.CD19-targeted T cells for hematologic malignancies:clinical experience to date[J].Cancer J,2015,21(6):470-474.
[15]孙海燕,陈伟红,肖佩华,等.肿瘤患者应用不同方式中心静脉置管的并发症及症状困扰[J].解放军护理杂志,2015,32(13):70-73.
[16]KANG B,KIM Y J,SUH S W,et al.Delirium and its consequences in the specialized palliative care unit:validation of the Korean version of Memorial Delirium Assessment Scale[J].Psychooncology,2019,28(1):160-166.
[17]BOND P,GOUDIE K.Identifying and managing patients with delirium in acute care settings[J].Nurs Older People,2015,27(9):28-32.
[18]GAUDREAU J D,GAGNON P,HAREL F,et al.Psychoactive medications and risk of delirium in hospitalized cancer patients[J].J Clin Oncol,2005,23(27):6712-6718.
[19]VAN GOOL W A,VAN DE BEEK D,EIKELENBOOM P.Systemic infection and delirium:when cytokines and acetylcholine collide[J].Lancet,2010,375(9716):773-775.
[20]SWART L M,VAN DER ZANDEN V,SPIES P E,et al.The comparative risk of delirium with different opioids:a systematic review[J].Drugs Aging,2017,34(6):437-443.
[21]MORYL N,KOGAN M,COMFORT C,et al.Methadone in the treatment of pain and terminal delirum in advanced cancer patients[J].Palliat Support Care,2005,3(4):311-317.
[22]ARAI Y C,NISHIHARA M,KOBAYASHI K,et al.Neurolytic celiac plexus block reduces occurrence and duration of terminal delirium in patients with pancreatic cancer[J].J Anesth, 2013,27(1):88-92.
[23]MATSUOKA H,YOSHIUCHI K,KOYAMA A,et al.Chemotherapeutic drugs that penetrate the blood-brain barrier affect the development of hyperactive delirium in cancer patients[J].Palliat Support Care,2015,13(4):859-864.
相似文献/References:
[1]姚媛淑,杜苗,蒋颖.家庭照顾者参与癌症患者疼痛管理的作用及障碍因素的综述[J].军事护理,2021,38(02):82.[doi:10.3969/j.issn.1008-9993.2021.02.022]
[2]任雅钰,赵海平.癌症患者自我同情的研究进展[J].军事护理,2021,38(06):58.[doi:10.3969/j.issn.1008-9993.2021.06.015]
[3]康婷婷,郑蔚,谷文燕,等.癌症患者养育忧虑问卷的汉化及信效度检验[J].军事护理,2021,38(11):33.[doi:10.3969/j.issn.1008-9993.2021.11.009]
KANG Tingting,ZHENG Wei,GU Wenyan,et al.Chinese Version of Parenting Concerns Questionnaire among Cancer Patients:Translation,Validity and Reliability[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(06):33.[doi:10.3969/j.issn.1008-9993.2021.11.009]
[4]肖霖,彭美芳,缪景霞,等.患者沟通模式量表的汉化及其在我国癌症人群中的信效度检验[J].军事护理,2021,38(11):46.[doi:10.3969/j.issn.1008-9993.2021.11.012]
XIAO Lin,PENG Meifang,MIAO Jingxia,et al.Translation of Patient Communication Pattern Scale and Its Reliability and Validity Testing among Cancer Patients[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(06):46.[doi:10.3969/j.issn.1008-9993.2021.11.012]
[5]吴媛,张慧超,王楠楠,等.虚拟现实技术在癌症患者负性情绪管理中的应用进展[J].军事护理,2022,39(05):61.[doi:10.3969/j.issn.1008-9993.2022.05.015]
[6]杨梦,林韦彤,马航霞,等.育龄癌症患者生育保护决策辅助工具应用现状[J].军事护理,2022,39(05):76.[doi:10.3969/j.issn.1008-9993.2022.05.019]
[7]刘砚燕,阮海珊,孙晶,等.癌症儿童和青少年化疗周期内多症状负担纵向调查分析[J].军事护理,2022,39(07):61.[doi:10.3969/j.issn.2097-1826.2022.07.016]
LIU Yanyan,RUAN Haishan,SUN Jing,et al.Multi-Symptom Burden of Children and Adolescents with Cancer Within Chemotherapy Cycle: A Longitudinal Study[J].Nursing Journal Of Chinese People's Laberation Army,2022,39(06):61.[doi:10.3969/j.issn.2097-1826.2022.07.016]
[8]谭佳宁,韩娟,范廷婷,等.中青年女性癌症患者决策准备的潜在类别分析[J].军事护理,2023,40(06):25.[doi:10.3969/j.issn.2097-1826.2023.06.007]
TAN Jianing,HAN Juan,FAN Tingting,et al.Preparation for Decision-making Among Young and Middle-aged Female Cancer Patients: A Latent Class Analysis[J].Nursing Journal Of Chinese People's Laberation Army,2023,40(06):25.[doi:10.3969/j.issn.2097-1826.2023.06.007]